Human Longevity, Inc.

Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Human Longevity was founded in 2013 and runs precision medicine clinics in San Diego and San Francisco, where its headquarters is located.

Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.

The company offers early detection programs that combine whole genome sequencing, whole body MRI, cardiac imaging and more than 100 blood biomarkers, with results reviewed by clinicians. Its assessments focus on four disease areas: cardiovascular disease, cancer, metabolic disease and neurodegeneration. Membership options range from a one-time genomics package to annual programs that add continuous monitoring, concierge primary care and consultations with Massachusetts General Hospital specialists. The company reports sequencing more than 75,000 genomes and has published over 20 peer-reviewed papers in journals including Nature Genetics and PNAS.